Extremely low-frequency electromagnetic fields activate the antioxidant pathway Nrf2 in a Huntington's disease-like rat model

Brain Stimulation

Volumn 6, Issue 1, 2013, Pages 84-86

  Tasset, Inmaculada ^a   Pérez Herrera, Aleyda ^b   Medina, Francisco J ^a   Arias Carrión, Óscar ^c   Drucker Colín, René ^d   Túnez, Isaac ^a  

^a Universidad de Cordoba   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antioxidants; Neurodegenerative disease; Nrf2; Oxidative stress; Transcranial magnitc stimulation

Indexed keywords

3 NITROPROPIONIC ACID; ANTIOXIDANT; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LEVEL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ELECTROMAGNETIC FIELD; HUNTINGTON DISEASE LIKE SYNDROME; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRANIAL MAGNETIC STIMULATION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; HUNTINGTON DISEASE; MALE; NF-E2-RELATED FACTOR 2; RATS; RATS, WISTAR; TRANSCRANIAL MAGNETIC STIMULATION;

RATTUS;

EID: 84873410083     PISSN: 1935861X     EISSN: 18764754     Source Type: Journal    
DOI: 10.1016/j.brs.2012.03.015     Document Type: Article

References (11)

1. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10 2004 18 25 [PubMed: 15298006]
2. O. Aria-Carrión Basic machanisms of rTMS: implications in Parkinson's disease Int Arch Med 1 2008 17 [PubMed: 18471317]
3. L. Baird, and A.T. Dinkova-Kostova The cytoprotective role of the Keap1-Nrf2 pathway Arch Toxicol 85 2011 241 272 [PubMed: 21365312]
4. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 7 1976 248 254 [PubMed: 942051]
5. F.M. Gutierrez-Mariscal, P. Perez-Martinez, J. Delgado-Lista, E.M. Yubero-Serrano, A. Camargo, and N. Delgado-Casado Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects Age 34 2012 389 403
6. M.C. Hyzinski-Garcia, M.Y. Vincent, R.E. Haskew-Layton, P. Dohare, R.W. Keller Jr., and A.A. Mongin Hypo-osmotic swelling modifies glutamate-glutamine cycle in the cerebral cortex and in astrocyte cultures J Neurochem 118 2011 140 152 [PubMed: 21517854]
7. F.J. Medina, and I. Tunez Huntington's disease: the value of transcranial meganetic stimulation Curr Med Chem 17 2010 2482 2491 [PubMed: 20491647]
8. V. Perez-De La Cruz, C. Gonzalez-Cortes, S. Galvan-Arzate, O.N. Medina-Campos, F. Perez-Severiano, and S.F. Ali Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III) Neuroscience 135 2005 463 474 [PubMed: 16111817]
9. A.Y. Shih, D.A. Johnson, G. Wong, A.D. Kraft, L. Jiang, and H. Erb Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress J Neurosci 23 2003 3394 3406 [PubMed: 12716947]
10. I. Tasset, V. Perez-De La Cruz, D. Elinos-Calderon, P. Carrillo-Mora, I.G. Gonzalez-Herrera, and A. Luna-Lopez Protective effect of tert-butylhydroquinone on the quinolinic-acid-induced toxicity in rat striatal slices: role of the Nrf2-antioxidant response element pathway Neurosignals 18 2010 24 31 [PubMed: 19797933]
11. I. Tunez, R. Drucker-Colin, I. Jimena, F.J. Medina, C. Munoz M del, and J. Pena Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease J Neurochem 97 2006 619 630 [PubMed: 16524377]